Greenwich Stock Price on December 13, 2021 Breakdown

GLSI -  USA Stock  

USD 8.50  0.55  6.92%

Greenwich Stock price history is provided at the adjusted basis, taking into account all of the recent filings. As of today, the current price of Greenwich Lifesciences is  8.50 , as last reported on the 28th of May, with the highest price reaching  8.68  and the lowest price hitting  7.97  during the day.
Greenwich Lifesciences holds Efficiency (Sharpe) Ratio of -0.25, which attests that the entity had -0.25% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Greenwich Lifesciences exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Greenwich Lifesciences risk adjusted performance of (0.32), and Market Risk Adjusted Performance of (22.71) to validate the risk estimate we provide.
  
Refresh
The current Net Income Common Stock is estimated to decrease to about (4.9 M). The current Price to Book Value is estimated to increase to 12.11, while Price to Earnings Ratio are projected to decrease to (75.00) .

Greenwich Lifesciences Main Headline on 13th of December 2021

Financial Statements
by SEC
Financial Statements and Exhibits. Other Events

Greenwich Lifesciences Valuation on December 13, 2021

It is possible to determine the worth of Greenwich Lifesciences on a given historical date. On December 13, 2021 Greenwich was worth 30.63 at the beginning of the trading date compared to the closed value of 29.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Greenwich Lifesciences stock. Still, in general, we apply an absolute valuation method to find Greenwich Lifesciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Greenwich Lifesciences' related companies.
 Open High Low Close Volume
  31.02    33.80    29.50    30.62    33,800  
12/13/2021
  30.63    31.38    28.14    29.00    43,200  
  28.42    28.67    26.11    26.19    48,100  
Backtest Greenwich Lifesciences  |  Greenwich Lifesciences History  |  Greenwich Lifesciences Valuation   PreviousNext  
Open Value 30.63
29.0
Closing Value
44.64
Upside

Greenwich Lifesciences Trading Date Momentum on December 13, 2021

On December 14 2021 Greenwich Lifesciences was traded for  26.19  at the closing time. The top price for the day was 28.67  and the lowest listed price was  26.11 . The trading volume for the day was 48.1 K. The trading history from December 14, 2021 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 9.69% . The overall trading delta against the current closing price is 1.59% .

Greenwich Lifesciences Fundamentals Correlations and Trends

By evaluating Greenwich Lifesciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Greenwich Lifesciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Greenwich financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Greenwich Lifesciences Stock history

Greenwich Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Greenwich is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Greenwich Lifesciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Greenwich Lifesciences historical stock prices may prove useful in developing a viable investing in Greenwich Lifesciences
Last ReportedProjected for 2022
Weighted Average Shares12.9 M10.4 M
Weighted Average Shares Diluted12.9 M10.4 M
Issuance Purchase of Equity Shares3.1 M3.2 M
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Greenwich Lifesciences Quarterly Market Capitalization

254.11 Million

Share

Greenwich Lifesciences Stock Technical Analysis

Greenwich Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Greenwich Lifesciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Greenwich Lifesciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Greenwich Lifesciences Period Price Range

Low
December 13, 2021
High

 30.63 

  

 29.00 

-1.63-5.32%

Greenwich Lifesciences May 28, 2022 Market Strength

Market strength indicators help investors to evaluate how Greenwich Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Greenwich Lifesciences shares will generate the highest return on investment. By undertsting and applying Greenwich Lifesciences stock market strength indicators, traders can identify Greenwich Lifesciences entry and exit signals to maximize returns

Greenwich Lifesciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Greenwich stock's direction in advance. Along with the technical and fundamental analysis of Greenwich Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Greenwich to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please check Risk vs Return Analysis. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.